Due to its amphiphilic feature, melatonin can cross the blood–retinal barrier, and can ameliorate nitric oxide (NO) and VEGF production, reducing vascular permeability in the retina of hypoxic rats, which may be crucial in preventing the development of CNV in exudative AMD [208]. The gene discussed is VEGFA; the disease is age-related macular degeneration.